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ABSTRACT
Objective: The objective of this study was to assess the activity Ulva lactuca polyphenols fraction in protecting the liver damage induced by high dose 
of paracetamol.
Methods: This study was performed using Wistar albino rats divided into six groups. Group 1 was the normal group. Groups 2, 3, 4, 5, and 6 received 
paracetamol (2 g/kg) for 7 days. In addition to paracetamol, Groups 3, 4, 5, and 6 received silymarin (100 mg/kg), U. lactuca polyphenols fraction 
at the doses of 50, 100, and 200 mg/kg, respectively, for 7 days. On the 8th day, serum and liver samples were collected from the animals and the 
hepatoprotective and antioxidant activities were assessed by studying the levels of liver marker enzymes, bilirubin, protein, reduced glutathione, and 
antioxidant enzymes.
Results: U. lactuca polyphenols fraction, at the tested doses, restored the levels of all serum markers and enzymes (aspartate aminotransferase, alanine 
aminotransferase, alkaline phosphatase, lactate dehydrogenase, γ-glutamyl transferase, total bilirubin, total protein, cholesterol, triglycerides, and 
reduced glutathione) and liver homogenate markers (reduced glutathione, superoxide dismutase, catalase, and glutathione peroxidase) significantly, 
in dose-dependent manner.
Conclusion: This study suggests that U. lactuca polyphenols fraction has a hepatoprotective effect against paracetamol-induced liver damage and 
possesses antioxidant activities.
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INTRODUCTION
Liver is an essential organ which is involved in detoxification of 
the exogenous xenobiotics, drugs and endogenous bile pigments, 
viral infections, and chronic alcoholism. While performing several 
detoxifications, liver is subjected to stress, leading to liver diseases 
resulting in liver damage and serious health problems and death. The 
liver regulates many important metabolic functions. Hepatic injury 
is associated with distortion of these metabolic functions [1]. Liver 
damage is a common pathology, which in most cases, involves oxidative 
stress and is characterized by a progressive evolution from steatosis to 
chronic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma [2]. 
As oxidative stress plays a central role in liver pathologies and their 
development, the use of antioxidants has been proposed as therapeutic 
agents to counteract liver damage.
In spite of advancements in modern medicine, hepatoprotective drugs 
are quite limited. The extended usage of remedies available in modern 
medicine is associated with severe side effects. The development or 
detection of new molecules effective in treating or preventing hepatic 
damage remains a challenge in the field of drug development [3]. It 
is generally recognized that indigenous drugs used traditionally by 
ethnic tribes or societies across the world can provide relief to patients 
with hepatic disorders. As a result, a conscious effort is undertaken 
to screen indigenous drugs used traditionally in different regions of 
the world, especially India and China. Plant-based drugs exhibiting 
hepatoprotective and antioxidant activities have been isolated from 
many species. A well-known potential hepatoprotective drug is, 
silymarin, isolated from Silybum marianum.
In recent times, the pharmaceutical and agri-food industries have 
been responsible for a great expansion in the demand for marine 
alga due to their significant applications as ingredients in functional 
foods and richness in antioxidant ingredients. It has been reported 
that marine alga are rich source of bioactive compounds such as 
terpenoids, phlorotannins, fucoidans, sterols and glycolipids, and the 
extracts or isolated pure components from marine alga possess a wide 
range of pharmacological properties such as anticancer, antibacterial, 
antifungal, antiviral, anti-inflammatory, anticoagulant, antioxidant, 
hypoglycemic, hypolipidemic, antimelanogenic, hepatoprotective, and 
neuroprotective activities [4,5]. Apart from these, marine alga are also 
a rich resource of dietary iodine and fibers which can also play a major 
role in improving the nutritional quality [6].
The green marine alga Ulva lactuca, commonly known as sea lettuce, 
has long been used as food and as a traditional medicinal agent to treat 
helminthic infections, fever, urinary diseases, and dropsy [7]. U.  actuca 
is rich in flavonoids and has potent antioxidant properties [8]. The 
hepatoprotective nature of U. lactuca against liver injury induced 
by D-galactosamine/endotoxin in rats has been established [9]. 
U. lactuca has also been shown to have potent hypocholesterolemic and 
antioxidant effects [10], antibacterial activity [11], nephroprotective 
activity [12], neuroprotective activity [13], and alpha-amylase and 
alpha-glucosidase inhibitory activity [14].
In view of these reports, the present investigation has been undertaken 
to evaluate the hepatoprotective and antioxidant activities of the 
polyphenols fraction of U. lactuca against paracetamol intoxicated liver 
damage in rat. Marine alga U. lactuca was selected for the present study 
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as it is an edible marine alga, easily available in the Gulf of Mannar Coast 
of Mandapam.
MATERIALS AND METHODS
Collection of marine alga sample
Fresh marine alga U. lactuca was collected from the intertidal regions 
of the Mandapam coast of Gulf of Mannar. The taxonomic identification 
of species was done using standard literature and taxonomic keys. 
The alga was identified and authenticated by the Principal Scientist, 
Central Salt and Marine Chemical Research Institute, Mandapam 
Camp. The collected samples were cleaned well with the seawater 
until unnecessary impurities, adhering sand particles, and extraneous 
matter such as epiphytes, pebbles, and shells were removed, and it was 
brought to the laboratory in sterile plastic bags containing seawater to 
prevent evaporation. It was then washed thoroughly with tap water and 
distilled water to remove the surface salty materials. It was air dried for 
1 week and later ground in an electric mixer. The powdered samples 
were subsequently stored in the refrigerator for future use.
Extraction of polyphenols fraction from U. lactuca
The powdered samples were then extracted with 80% ethanol for 24 h 
under continuous shake at 20°C. The extracts were then concentrated 
in a rotary evaporator under reduced pressure at 40°C [15]. The solid 
mass obtained was stored at 4°C. At the time of administration to 
the rats, the polyphenols fraction was dissolved in distilled water to 
required concentration.
Experimental animals
Male Swiss albino mice weighing 20–25 g and male Wistar albino 
rats weighing 150–200 g were used for the study. The animals were 
maintained in well-ventilated rooms with 12:12 light/dark cycle, 
24±2°C temperature, and 30–70% relative humidity, in polypropylene 
cages. Standard rat rodent pellets (M/s. Hindustan Lever Ltd., Mumbai) 
and water were provided ad libitum. Animals were acclimatized to the 
laboratory conditions 1 week before the initiation of the study. The study 
was approved by the Institutional Animal Ethical Committee (IAEC) 
constituted for the purpose of CPCSEA (IAEC/APCAS/01/2015/01).
Acute toxicity studies
Acute oral toxicity was performed according to OECD-423 
guidelines [16]. Male Swiss albino mice weighing 20–25 g selected 
by random sampling technique were used in the study. The animals 
were fasted overnight, provided only water after which polyphenols 
fraction was administered to the groups (3 mice/group) orally at the 
dose level of 5 mg/kg body weight by gastric intubation and the groups 
were observed for 14 days. If mortality was observed in 2 or 3 animals, 
then the dose administered was considered as a toxic dose. However, if 
mortality was observed in one animal, then the same dose was repeated 
again to confirm the toxic dose. If no mortality was observed, then 
higher (50, 300, and 2000 mg/kg) doses of polyphenol fraction were 
employed for further toxicity studies. The animals were observed for 
toxic symptoms such as behavioral changes, locomotion, convulsions, 
and mortality.
Induction of hepatic damage
Liver damage was induced in rats by paracetamol (acetaminophen) 
suspended in 0.5% Tween-80 and administered p.o., at a dose of 2 g/kg 
body weight.
Experimental design
Male Wistar albino rats (male) weighing between 150 and 200 g were 
divided into six groups of six animals each. The weight range of the 
animals was equally distributed throughout the groups.
• Group 1: Control rats received distilled water orally for 7 days.
• Group 2: Treated with paracetamol (2 g/kg) for 7 days.
• Group 3: Treated with paracetamol (2 g/kg) and silymarin 
(100 mg/kg) dissolved in water for 7 days.
• Group 4: Treated with paracetamol (2 g/kg) and U. lactuca 
polyphenols fraction (50 mg/kg) dissolved in water for 7 days.
• Group 5: Treated with paracetamol (2 g/kg) and U. lactuca 
polyphenols fraction (100 mg/kg) dissolved in water for 7 days.
• Group 6: Treated with paracetamol (2 g/kg) and U. lactuca 
polyphenols fraction (200 mg/kg) dissolved in water for 7 days.
Animals were kept starved overnight on the 7th day. The next day, all the 
animals were sacrificed under light ether anesthesia. Blood was collected 
by direct cardiac puncture into sterilized dry centrifuge tubes and 
allowed to coagulate for 30 min at 37°C. The clear serum was separated 
at 2500 rpm for 10 min and subjected to various biochemical estimations. 
100 mg of liver issue from each rat was used for antioxidant study.
Biochemical estimations
The separated serum was subjected to biochemical estimation of 
different parameters such as alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) [17], alkaline phosphatase (ALP) [18], lactate 
dehydrogenase (LDH) [19], γ-glutamyl transferase (γ-GT) [20], total 
bilirubin [21], total protein [22], cholesterol [23], triglycerides [24], 
and reduced glutathione [25].
The antioxidant status
One hundred milligram of liver tissue was weighed and homogenate 
was prepared in 10 ml Tris-hydrochloric acid buffer (0.5 M; pH 7.4) at 
4°C. The homogenate was centrifuged and the supernatant was used 
for the estimation of reduced glutathione [25] and assay of antioxidant 
enzymes such as superoxide dismutase [26], catalase [27], and 
glutathione peroxidase [28].
Statistical analysis
One-way analysis of variance followed by Dunnett’s t-test was applied 
for determining the statistical significance of difference between 
experimental groups. p<0.05 was considered to be statistically significant.
RESULTS AND DISCUSSION
All the doses (5, 50, 300, and 2000 mg/kg) of U. lactuca polyphenols 
fraction tested for acute oral toxicity studies were found to be non-toxic. 
According to the OECD-423 guidelines for acute oral toxicity, the LD50 
dose of 2000 mg/kg and above is categorized as unclassified. U. lactuca 
polyphenols fraction did not produce any mortality even at the highest 
dose (2000 mg/kg) employed, and hence, U. lactuca polyphenols fraction 
was considered to be safe for further pharmacological screening. Three 
submaximal doses (50, 100, and 200 mg/kg) were employed for further 
pharmacological investigations.
Liver is the largest organ and is a target for toxicity due to its role 
in clearing and metabolizing chemicals through the process of 
detoxification [29]. Drug-induced liver disorders occurring frequently 
can be life threatening and mimic all forms of liver diseases [30]. 
Paracetamol is also a drug which is capable of causing liver disorders, if 
it is given continuously.
The paracetamol-induced liver disorders were treated with U. lactuca 
polyphenols fraction for 7 days. Estimating the activities of serum 
marker enzymes such as AST, ALT, ALP, γ-GT, and LDH is a tool for 
the assessment of the liver function. When the liver cell plasma 
membrane is damaged, a variety of enzymes normally located in the 
cytosol are released into the bloodstream. Their estimation is a useful 
quantitative marker of the extent and type of hepatocellular damage 
identification [31]. An obvious sign of hepatic injury is the leakage of 
cellular enzymes such as AST, ALT, and ALP [32].
There was a significant increase (p<0.01) in the levels of AST, ALT, 
ALP, LDH, γ-GT, total bilirubin, total cholesterol, and triglycerides and 
a significant decrease (p<0.01) in total protein and plasma reduced 
glutathione in paracetamol-treated animals from those of the control 
group. Administration of U. lactuca polyphenols fraction (50, 100, and 
200 mg/kg) decreased the reduced levels of AST, ALT, ALP, LDH, γ-GT, 
total bilirubin, total cholesterol, and triglycerides in a dose-dependent 
manner (p<0.01). The levels of total protein and plasma reduced 
57
Asian J Pharm Clin Res, Vol 12, Issue 4, 2019, 55-58
 Ravindran and Sadiq 
glutathione were increased significantly by the administration of 
U. lactuca polyphenols fraction in a dose-dependent manner. Silymarin, 
the reference drug restored the altered levels of enzymes significantly 
(p<0.01) (Table 1).
Hypoalbuminemia is very common in advanced chronic liver 
diseases. Hence, decrease in total protein content can be considered 
as a useful index of the severity of cellular dysfunction in chronic 
liver diseases. The decreased level of total proteins recorded in 
the serum of paracetamol-treated rats suggests the severity of 
hepatotoxicity. The restoration of near normalcy in total protein 
content of the serum of U. lactuca polyphenols fraction treated 
rats further elucidates the hepatoprotective effect of U. lactuca 
polyphenols fraction.
Decreased activities of the antioxidant enzymes, superoxide 
dismutase, catalase, and glutathione peroxidase observed in the liver 
homogenate of paracetamol-treated rats indicate the extensive liver 
damage induced by the hepatotoxin (p<0.01). The tendency of these 
enzymes to return to near normalcy in U. lactuca polyphenols fraction 
administered groups (50, 100, and 200 mg/kg) in a dose-dependent 
manner is a clear indication of hepatoprotective effect of U. lactuca 
polyphenols fraction extract through antioxidant mechanism (p<0.01) 
(Table 2).
Experimental and epidemiological studies indicate the involvement of 
oxidative stress in the pathogenesis and progression of many chronic 
diseases [33]. It is known that oxygen, essential for maintaining 
life, sometimes becomes toxic and results in the generation of most 
aggressive agents such as reactive oxygen species (ROS). The high 
reactivity of ROS may activate a host of disorders in the body resulting 
in tissue damage and necrosis in many instances [34]. The body has an 
effective mechanism to prevent and neutralize the free radical-induced 
damage. This is achieved by a set of endogenous antioxidant enzymes 
such as superoxide dismutase, catalase, and glutathione peroxidase. 
When the equilibrium between ROS production and antioxidant 
defense is lost, oxidative stress results, which through a series of 
events, deregulate the cellular functions, leading to various pathological 
conditions [35].
It is probable that natural antioxidants strengthen the endogenous 
antioxidant defense from ROS damage and restore the optimal 
equilibrium by neutralizing the reactive species. They are gaining 
enormous importance by virtue of their critical role in disease 
prevention.
CONCLUSION
It can be said that U. lactuca polyphenols fraction has exhibited a 
liver protective effect against paracetamol-induced hepatotoxicity 
and possessed antioxidant activities. Thus, U. lactuca, commonly 
used as a food and as a traditional medicinal agent, is found to have 
hepatoprotective effect and antioxidant activities. U. lactuca is a 
seaweed, but it is proven to possess immense potential by this study. 
Efforts are in progress to isolate and purify the active principle involved 
in the hepatoprotective efficacy of this marine alga.
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Table 1: Effect of Ulva lactuca polyphenols fraction on serum marker enzymes, protein, bilirubin, and reduced glutathione
Parameters Group I Group II Group III Group IV Group V Group VI
ALT (IU/L) 48.50±2.09 161.00±7.26a* 52.17±1.92b* 65.00±3.07b* 58.00±2.74b* 52.83±2.49b*
AST (IU/L) 82.00±3.71 213.67±±10.45a* 84.83±4.13b* 111.83±5.37b* 99.83±±4.79b* 90.83±4.25b*
ALP (IU/L) 135.00±6.60 291.33±11.08a* 139.50±6.61b* 181.83±9.52b* 162.33±8.50b* 147.50±7.23b*
LDH (IU/L) 110.33±5.74 182.17±8.69a* 112.67±5.36b* 140.00±7.30b* 125.00±6.52b* 113.67±5.86b*
γ-GT (IU/L) 3.18±0.15 6.58±0.31a* 3.25±0.17b* 4.17±0.31b* 3.72±0.28b* 3.38±0.18b*
Total bilirubin (mg/dL) 0.78±0.04 2.48±0.13a* 0.80±0.04b* 1.02±0.06b* 0.90±0.05b* 0.82±0.05b*
Total protein (g/dL) 7.33±0.35 5.03±0.26a* 7.25±0.30b* 5.80±0.29b* 6.50±0.33b* 7.23±0.39b*
Total cholesterol (g/dL) 96.33±4.33 200.17±8.98a* 101.33±5.22b* 130.50±5.73b* 116.50±5.12b* 105.83±4.37b*
Triglycerides (g/dL) 86.33±4.09 286.50±10.16a* 89.00±4.55b* 115.00±6.19b* 102.67±5.53b* 93.33±4.78b*
Reduced glutathione (mg/dL) 32.00±1.31 17.50±0.98a* 30.83±1.21b* 22.67±0.99b* 25.50±1.10b* 28.33±1.22b*
Group I – Control; Group II – PCM; Group III – PCM+Silymarin; Group IV – PCM+ULPF 50 mg/kg; Group V – PCM+ULPF 100 mg/kg; Group VI – PCM+ULPF 
200 mg/kg. The observations are given as Mean±SEM, n=6; *p<0.01; aGroup I versus Group II; bGroup II versus Groups III, IV, V, and VI. PCM: Paracetamol; ULPF: Ulva 
lactuca polyphenols fraction, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, ALP: Alkaline phosphatase, LDH: Lactate dehydrogenase, γ-GT: γ-Glutamyl 
transferase
Table 2: Effect of Ulva lactuca polyphenols fraction on liver homogenate reduced glutathione and antioxidant enzymes
Parameters Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
Liver reduced glutathione (mg/100 g wet 
tissue)
48.50±2.52 21.00±1.10a* 47.50±2.13b* 35.17±1.94b* 39.33±2.17b* 43.67±2.14b*
1Superoxide dismutase 8.25±0.45 4.30±0.23a* 8.02±0.46b* 6.18±0.39b* 6.93±0.43b* 7.70±0.24b*
2Catalase 57.50±2.20 24.83±1.24a* 55.50±2.92b* 41.17±1.89b* 46.17±2.12b* 51.33±±2.45b*
3Glutathione peroxidase 8.73±0.41 4.35±0.24a* 8.42±0.39b* 6.12±0.38b* 6.85±0.43b* 7.62±0.38b*
Group I – Control; Group II – PCM; Group III – PCM+Silymarin; Group IV – PCM+ULPF 50 mg/kg; Group V– PCM+ULPF 100 mg/kg; Group VI– PCM+ULPF 200 mg/kg. 
1Superoixde dismutase is expressed as 50% inhibition of epinephrine autoxidation/min/mg protein. 2Catalase is expressed as µmoles of H2O2 decomposed/min/
mg protein. 3Glutathione peroxidase is expressed as µmoles of glutathione oxidized/min/mg protein. The observations are given as Mean±SEM, n=6; *p<0.01; aGroup I 
versus Group II; bGroup II versus Groups III, IV, V, and VI. PCM: Paracetamol; ULPF: Ulva lactuca polyphenols fraction
58
Asian J Pharm Clin Res, Vol 12, Issue 4, 2019, 55-58
 Ravindran and Sadiq 
REFERENCES
1. Wolf PL. Biochemical diagnosis of liver disease. Indian J Clin Biochem 
1999;14:59-90.
2. Anup S, Shivanandappa T. Hepatoprotective effect of the root extract 
of Decalepis hamiltonii against carbon tetrachloride-induced oxidative 
stress in rats. Food Chem 2010;118:411-7.
3. Ahmad I, Aqil F, Owais M. Modern Phytomedicine: Turning Medicinal 
Plants into Drugs. New York: John Wiley and Sons; 2006.
4. Liu L, Heinrich M, Myers S, Dworjanyn SA. Towards a better 
understanding of medicinal uses of the brown seaweed Sargassum in 
traditional Chinese medicine: A phytochemical and pharmacological 
review. J Ethnopharmacol 2012;142:591-619.
5. Chakraborty K, Paulraj R. Sesquiterpenoids with free radical 
scavenging properties from marine macroalga Ulva fasciata Delile. 
Food Chem 2010;122:31-41.
6. Gupta S, Abu-Ghannam N. Recent developments in the application 
of seaweeds or seaweed extracts as a means for enhancing the safety 
and quality attributes of foods. Innov Food Sci Emerg Technol 
2011;12:600-9.
7. Kim IH, Lee DG, Lee SH, Ha JM, Ha BJ, Kim BJ, et al. 
Antibacterial activity of Ulva lactuca against Methicillin-resistant 
Staphylococcus aureus (MRSH). Biotechnol Bioprocess Eng 
2007;12:579-82.
8. Meenakshi S, Gnanambigai DM, Mozhi ST, Arumugam M, 
Balasubramanian T. Total flavanoid and in vitro antioxidant activity of 
two seaweeds of Rameshwaram coast. Glob J Pharmacol 2009;3:59-62.
9. Sathivel A, Raghavendran HR, Devaki T. Hepatoprotective nature 
of seaweeds (Ulva lactuca/Gracilaria edulis) against liver injury 
induced by D-Galactosamine/endotoxin in rats. Seaweed Res Utlin 
2003;25:109-11.
10. Hassan S, El-Twab SA, Hetta M, Mahmoud B. Improvement of 
lipid profile and antioxidant of hypercholesterolemic albino rats by 
polysaccharides extracted from the green alga Ulva lactuca Linnaeus. 
Saudi J Biol Sci 2011;18:333-40.
11. Pushparaj A, Raubbin RS, Balasankar T. Antibacterial activity 
of Kappaphycus alvarezii and Ulva lactuca extracts against 
humanpathogenic bacteria. Int J Curr Microbiol Appl Sci 2014;3:432-6.
12. Mahmoud HM, Hussein UL. Suppression of N-nitrosodiethylamine 
induced oxidative renal toxicity by sulphatedpolysaccharide and aqueous 
extract of Ulva lactuca in rats. Int J Pharm Pharm Sci 2014;6:248-53.
13. Suganthy N, Karutha Pandian S, Pandima Devi K. Neuroprotective 
effect of seaweeds inhabiting South Indian coastal area (Hare Island, 
Gulf of Mannar marine biosphere reserve): Cholinesterase inhibitory 
effect of Hypnea valentiae and Ulva reticulata. Neurosci Lett 
2010;468:216-9.
14. Reka P, Banu AT, Seethalakshmi M. Alpha amylase and alpha 
glucosidase inhibition activity of selected edible seaweeds from south 
coast area of India. Int J Pharm Pharm Sci 2017;9:64-8.
15. Heo SJ, Cha SH, Lee KW, Jeon YJ. Antioxidant activities of red alga 
from Jeju Island. Alga 2006;21:149-56.
16. Ecobichon DJ. The Basis of Toxicology Testing. 2nd ed. New York: 
CRC Press; 1997. p 43-60.
17. Reitman S, Frankel S. A colorimetric method for the determination of 
serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J 
Clin Pathol 1957;28:56-63.
18. King EJ, Armstrong AR. Determination of serum and bile phosphatase 
activity. Can Med Assoc J 1934;31:56-63.
19. King J. The hydrolase and alkaline phosphatase. In: Practical Clinical 
Enzymology. London: Nostrand Co. Ltd.; 1965. p. 191.
20. Rosalki SB, Rau D. Serum -glutamyl transpeptidase activity in 
alcoholism. Clin Chim Acta 1972;39:41-7.
21. Malloy HT, Evelyn EA. The determination of bilirubin with 
photoelectric colorimeter. J Biol Chem 1937;119:481-5.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement 
with the folin phenol reagent. J Biol Chem 1951;193:265-75.
23. Parekh AC, Jung DH. Cholesterol determination with ferric acetate-
uranium acetate and sulfuric acid-ferrous sulfate reagents. Anal Chem 
1970;42:1423-7.
24. Foster LB, Dunn RT. Stable reagents for determination of serum 
triglycerides by a colorimetric hantzsch condensation method. Clin 
Chem 1973;19:338-40.
25. Moron MS, Depierre JN, Mannervik B. Levels of glutathione, 
glutathione reductase and glutathione-S-transferase activity in rat lung 
and liver. Biochim Biophys Acta 1979;582:67-78.
26.	 Misra	ΗP,	Fridovich	I.	The	role	of	superoxide	anion	in	the	autoxidation	
of epinephrine and a simple assay for superoxide dismutase. J Biol 
Chem 1972;247:3170-5.
27.	 Takahara	 S,	 Hamilton	 ΒΗ,	 Neel	 JV,	 Kobara	 ΤΥ,	 Ogura	 Υ,	
Nishimiua	 ΕΤ.	 Hypocatalasemia,	 a	 new	 genetic	 carrier	 state.	 J	 Clin	
Invest 1960;39:610-9.
28. Rortruck JT, Pope AL, Ganther HE, Swanson AB. Selenium: 
Biochemical roles as a component of glutathione peroxidase. Science 
1973;179:588-90.
29. Larrey D. Drug induced liver disease. J Hepatol 2003;32:77-88.
30. Watkins PB, Seef LB. Drug induced liver injury: Summary of a single 
topic clinical research committee. Hepatology 2006;43:618-31.
31.	 Mitra	 SK,	 Venkataranganna	 MV,	 Sundaram	 R,	 Gopumadhavan	 S.	
Protective effect of HD-03, a herbal formulation against various 
hepatotoxic agents in rats. J Ethnolpharmacol 1998;63:181-6.
32. Dwivedi Y, Rastogi R, Garg NK, Dhandan DM. Prevention of 
paracetamol-induced hepatic damage in rats by picrolir, the standardized 
active fraction from Picorhiza kurrao. Phytother Res 1991;5:115-9.
33.	 Tewari	S,	Gupta	V,	Bhattacharya	S.	Comparative	study	of	antioxidant	
potential of tea with and without additives. Indian J Physiol Pharmacol 
2000;44:215-9.
34.	 Prasad	 VS,	 Venkatachalam	 SR,	 Chander	 R,	 Thomas	 P.	 Dietary	
antioxidants-natural defense against disease. Aryavaidyan 
1999;12:149-58.
35. Bandyopadhyay U, Das D, Banerjee KR. Reactive oxygen species: 
Oxidative damage and pathogenesis. Curr Sci 1999;77:658-66.
